EligoChem
EligoChem design, synthesise and procure unique amphiphilic compound libraries for use in drug discovery.
About EligoChem
EligoChem has developed a proprietary and patentable technology that facilitates the design of highly water-soluble drugs that are absorbed well by the human body. One in fifteen known drug compounds have this combination of properties, but they are present in only one in ten thousand compounds in current pharma screening collections. This technology is particularly suited to antibiotic drug discovery.
Company Facts
- Headquarters
- Sandwich
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00001_00010
- Funding Stage
- seed
- Total Funding
- $4,800,000
- Last Funding Type
- grant
- Last Funding Date
- 2017-08-28
- Website
- eligochem.com
Industries & Categories
App Discovery, Biotechnology, Pharmaceutical
Social Links
Canonical: https://fsome.com/organization/eligochem-109240 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.